Inputs: momentum, trendVelocity
Mixed signal: momentum 55/100, trend 52/100.
Prediction result · Ensemble engineUpdated 5:00 AM
AMGNAMGN stock price outlook
$465.30+0.99% since prev closeNeutral
AMGN is up 0.99% since the previous close on the latest cached quote at $465.30. Mixed signal: momentum 55/100, trend 52/100.
Universal leanStock
AMGN
AMGN
$465.30+0.99%
LEANNEUTRAL / wait for cleaner tape
WHY
- AMGN is up 0.99% since the previous close on the latest cached quote at $465.30. Mixed signal: momentum 55/100, trend 52/100.
- Bull input: Sentiment 62/100 with price up 1.0% confirms catalyst follow-through.
- Bear input: No bearish case in the sources.
RISK
Quote row is current from the latest cached feed.
INVALIDATE
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · Lean
live data
Cached quote refreshed 2026-11-02T05:00:56.841Z. Change is measured since the previous close.
Quote source
Cron batch chart feed 2026-11-02T05:00:56.841Z
Move since previous close
+0.99%
News Sentiment62/100
Price Momentum55/100
Trend Velocity52/100
Volatility Risk42/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on AMGN
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgeLeanNeutral
Inputs: newsSentiment, dayChange
Sentiment 62/100 with price up 1.0% confirms catalyst follow-through.
Inputs: unusualVolume, dayChange
Volume read 45/100 with price drift 1.0% — no clear footprint.
Inputs: volatilityRisk, momentum
Vol regime 42/100 is mid-range — no edge.
Inputs: pctOfRange, trendVelocity
Mid-range positioning — no edge from range alone.
Inputs: newsSentiment, weekChange
Sentiment 62/100 vs week change 4.7% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price within 0.0% of the 50d SMA — no clear structural read.
Inputs: momentum, trendVelocity
Oscillator at 54 — neutral zone.
Inputs: momentum, dayChange, vsSma50
Momentum 55/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 62/100 and weekly change 4.7% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 45/100 does not show a dry-up signal.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 42/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Range position 56% is too middle-of-the-road to matter.
Inputs: newsSentiment, momentum, weekChange
Sentiment 62/100 and momentum 55/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
50d SMA distance 0.0% is not decisive.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 54 does not show a rebound edge.
Why the ensemble agrees
- Mixed signal: momentum 55/100, trend 52/100.
- Price within 0.0% of the 50d SMA — no clear structural read.
- Momentum 55/100 is not strong enough to confirm a breakout.
Counter-trees
- Sentiment 62/100 with price up 1.0% confirms catalyst follow-through.
Bull Case
- Sentiment 62/100 with price up 1.0% confirms catalyst follow-through.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Zacks Investment Research57
Amgen (AMGN) increases despite market slip: Here's what you need to know
10/29/2026, 1:50:03 PM
FinancialContent Markets62
Amgen (AMGN) reports Q3: everything you need to know ahead of earnings
11/1/2026, 4:01:00 PM
Zacks Investment Research69
Here's why Amgen (AMGN) is a strong growth stock
10/20/2026, 5:45:42 AM
Key stats
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Market cap
- $251.94B
- 52-week range
- $468.27/$288
- Volume
- 3,290,628
- Avg volume
- 2,755,936
- Analyst 1-yr target
- $425.00
- Dividend (annual)
- $10.08
- Yield
- 2.19%
- Ex-dividend
- Aug 21, 2026
- Exchange
- NASDAQ-GS
Source: Nasdaq public quote data. Research only.
Earnings Intelligence
Next
Nov 3, 2026
Estimate
$5.74
Actual
$6.29
- • Last report Aug 4, 2026 (Jun 2026): EPS $6.29 vs $5.6 expected, +12.32% surprise.
- • Beat estimates in 4 of the last 4 quarters.
- • Next report expected Nov 3, 2026, consensus EPS $5.74 (Zacks estimate via Nasdaq; the company may confirm a different date).
Risk Warnings
- • Quote row is current from the latest cached feed.
- • Quotes can be delayed. Research only, not investment advice.
AMGN questions
What is the MarketPicks AI signal for AMGN stock (AMGN)?
As of Nov 2, 12:00 AM ET, the ensemble reads neutral on AMGN — no consensus — 15 of 16 bots holding, with 1 bull, 0 bear and 15 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest AMGN price on MarketPicks?
AMGN was $465.30 on the latest quote (Nov 2, 12:00 AM ET), +0.99% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for AMGN mean?
Scores run from 0 to 100, with 50 neutral. AMGN shows momentum 55/100, trend velocity 52/100 and volatility risk 42/100, with news sentiment at 62/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.